Eastside Research Associates — Redmond, Washington

Public research footprint of Eastside Research Associates, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Obesity · Type 2 Diabetes · COVID-19 SARS-CoV-2 Infection · Atherosclerotic Cardiovascular Disease (ASCVD)

Recently updated registry entries

NCT07223593 — Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease (Recruiting)
NCT06897475 — A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a… (Recruiting)
NCT07223840 — A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Eastside Research Associates?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.